Early detection of neuropathologies affecting drivers
Official title: Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Run by University Hospital Olomouc · NCT07360886 · Data updated 2026-11-12
This project tests whether simple clinical and motor/cognitive tests can spot early signs of multiple sclerosis or Parkinson's disease that affect people who drive.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Hospital Olomouc Academic / other |
| Locations | 1 site (Olomouc, Olomouc Region) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07360886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Drivers aged 18–85 with a confirmed diagnosis of multiple sclerosis or Parkinson's disease who hold a valid driver's license, actively drive, meet the study's diagnostic criteria, have no dementia, and meet the study limits for MS (EDSS ≤ 6.5) and for PD (within the study's Hoehn and Yahr cutoff).
✕Probably not a fit
People with dementia, non-drivers, or those with advanced disability (for example MS with EDSS >6.5 or PD above the study's Hoehn and Yahr cutoff) are unlikely to benefit from the screening approach tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project uses a two-phase, observational design starting with healthy volunteers completing the Vienna Test System (VTS) to establish baseline performance. In the clinical phase, people with diagnosed multiple sclerosis or Parkinson's disease complete a basic neurological exam (including MoCA, 25-Foot Walk, SDMT, and Nine-Hole Peg Test) followed by VTS testing. Patients are staged with EDSS for MS and Hoehn and Yahr for PD to relate disease severity to test results. The goal is to find which easily accessible clinical tests best correlate with VTS outcomes and to develop a practical risk equation and targeted training approaches to support safe driving.
Why it matters
Potential benefit: If successful, clinicians could use simple bedside tests and a calculator to detect driving-relevant MS or Parkinson's impairments earlier and offer interventions to improve road safety.
How similar studies have gone: Previous research has linked cognitive and motor tests to driving performance, but combining simple clinical bedside tests with Vienna Test System results to create a practical risk calculator is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Person after signing informed consent. * After meeting the valid diagnostic criteria for the given neurological diagnosis. * Possession of a valid driver's license and proof of active driving. * Age limit 18 - 85 years. Exclusion Criteria: * Proven diagnosis of dementia based on a current psychological examination (MMSE 24 points or less). * Diagnosis of a disease or condition that, according to Czech Law. No. 277/2004 Coll., on medical fitness to drive motor vehicles, as amended (especially Law No. 204/2025 Coll.), prevents or significantly limits the ability to drive a motor vehicle safely (e.g. dementia, epilepsy, severe disorders of consciousness). * Age less than 18 years. * Age more than 85 years. * In the second cohort (patients with Multiple Sclerosis), proven and treated relapse in the last 6 weeks before inclusion in the study. * In the MS cohort, current EDSS \> 6.5 points. * For the PD cohort, the current Hoehn and Yahr scale score is greater than or equal to 4. * For both cohorts, evidence of parainfectious deterioration as demonstrated by laboratory testing.
Where it's running
-
University hospital Olomouc
Olomouc, Olomouc Region, Czechia Recruiting
Study contacts
- Study coordinator: Dalibor Zimek, M.D.
- Email: Dalibor.Zimek@fnol.cz
- Phone: +420 702 048 036
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Telehealth rehabilitation for neurodegenerative diseases
This study is testing if online rehabilitation programs can help people with Parkinson's Disease and Multiple Sclerosis feel better compared to traditional education methods.
-
Digital app for monitoring speech and health in neurodegenerative conditions
This study is testing a digital app that records and analyzes speech to see if it can help monitor and detect neurodegenerative conditions like dementia and Parkinson's disease in both patients and healthy volunteers.
-
Assessing gait and balance in rare neurological diseases
This study looks at how walking and balance are affected in people with rare neurological diseases to better understand their challenges and risks of falling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.